chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt a little dizzy; Normal injection site/upper arm pain at first; Joint pain; Headache; Fatigue; Lack of sleep; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151), via an unspecified route of administration in the right arm on 06Apr2021 at 13:15 (at the age of 66-year-old), as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have a history of allergies to any food or medications or other products. Concomitant medications included cromoglicate sodium (NASALCROM), ascorbic acid (VITAMIN C), calcium (MANUFACTUREER UNKNOWN) and vitamin d (MANUFACTURER UNKNOWN) and multi vitamins (MANUFACTURER UNKNOWN) all for an unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in the right arm on 16Mar2021 at 12:00 (at the age of 66-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 20:00, the patient experienced normal injection site/upper arm pain at first. On 06Apr2021, the patient experienced joint pain, headache and fatigue and lack of sleep. On 07Apr2021, the patient felt a little dizzy when the patient first woke up due to lack of sleep because of joint pain. No therapeutic measures were taken for the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events normal injection site/upper arm pain at first, joint pain, headache, fatigue, lack of sleep and felt a little dizzy were recovered on 07Apr2021.   No follow-up attempts are needed. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was provided regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 19-OCT-2009, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at a non-profit facility, as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 16-OCT-2014, the patient was treated by a physician/MD at a hospital for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. The patient was prescribed VALTREX, oxycodone, KEFLEX, for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the herpes zoster was unknown. Causality assessment was related. Additional information has been requested.
I started to have some rectal bleeding and it increased as time went by and I started to have loss stools.  It turned out I had developed ulcerated colitus.   I ended  up in hospital from June 16th to  June 25th.  I am still under treatment for the problem.
I received the Moderma shot Tuesday and have been sick ever since.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Jun-2021 and was forwarded to Moderna on 11-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I received the Moderma shot Tuesday and have been sick ever since.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I received the Moderma shot Tuesday and have been sick ever since.). At the time of the report, ILLNESS (I received the Moderma shot Tuesday and have been sick ever since.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.     No concomitant medication was reported. Treatment medication was not provided.
Headache, shivers, flu like symptoms. Took ibuprofen and TYLENOL.
I developed dermatographism a few days after my second dose. I get itchy red bumps or just raised red skin with white around it whenever I rub or scratch an area of my skin. It has persisted all the way from April and is not going away.
Lost hearing in the left ear; Tinnitus (ringing in the left ear); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DEAFNESS (Lost hearing in the left ear) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included LOSARTAN, AMOXICILLIN and PREDNISONE for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced TINNITUS (Tinnitus (ringing in the left ear)). On an unknown date, the patient experienced DEAFNESS (Lost hearing in the left ear) (seriousness criterion medically significant). At the time of the report, DEAFNESS (Lost hearing in the left ear) and TINNITUS (Tinnitus (ringing in the left ear)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Acoustic stimulation tests: abnormal (abnormal) Hearing loss.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was taking other unspecified concomitant  medications.  On an unknown date, the patient went to an urgent care ear throat specialist with a chief complaint of tinnitus and had a hearing test.  The patient was diagnosed with hearing loss in the left ear and was given a steroid prescription.  Based on the current available information and the temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and the temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.
Massive headache within 1 hour of injection that lasted all evening.  Dizziness, Aches, Nausea that led to vomiting.
Syncope, Patient recovered after just a few minutes and was able to leave the pharmacy with her family.
Pt recvd vax & 28SEP92 exp total body rash, red large hives, itchy treated w/DPH;
Estimated due date: 02/16/2021 Essentially I just had tiredness, body aches and fever (101.8F), the reason I could not go to work is because I was extremely tired and unable to focus. Symptoms lasted 12-18 hrs.
No adverse event; A patient was administered a dose of the Moderna COVID-19 vaccine bivalent after the published expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient was administered a dose of the Moderna COVID-19 vaccine bivalent after the published expiration date) and NO ADVERSE EVENT (No adverse event) in a 12-month-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 069H22A) for COVID-19 prophylaxis.     The patient received other vaccines in the 4 weeks prior to COVID-19 vaccine.  Previously administered products included for Product used for unknown indication: VARICELLA VACCINE, MMR and HEPATITIS A. Past adverse reactions to the above products included No adverse event with HEPATITIS A, MMR and VARICELLA VACCINE.    On 20-Jun-2023, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient was administered a dose of the Moderna COVID-19 vaccine bivalent after the published expiration date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A patient was administered a dose of the Moderna COVID-19 vaccine bivalent after the published expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (A patient was administered a dose of the Moderna COVID-19 vaccine bivalent after the published expiration date).    No concomitant medication was reported. No symptoms were reported. No additional doses were reported. No treatment medication was reported
I've lost taste; (I've lost) smell; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (I've lost taste) and ANOSMIA ((I've lost) smell) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (I've lost taste) and ANOSMIA ((I've lost) smell). At the time of the report, AGEUSIA (I've lost taste) and ANOSMIA ((I've lost) smell) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information provided.
pt recv 2 doses of vax & had seronegative post vax titers;
Developed erythematous nodular pruritiis numular macules, some with purpuric centers, some that coalesced-raised edges, raised centers. No bull's eye lesions noted. Treated with dexamethasone, and then prednisolone. Held other meds x 1 day. Also, used po Benadryl.
1-2 weeks post shot in right arm had sorness and aching with weakness and tremors. Reported to PCP at that time and made appointment.  Reported to Employee health at place of employment where shot was administered.  Saw MD at employee health and underwent physical therapy, MRI, orthopedic consultation and 2 different neurologist consultations. Had adverse reaction to predisone pack as well. Currently have on going soreness, aching, weakness, and tremors.
received the first dose of Shingrix on Dec 26th, 2019 / has not received the second dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 26th December 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
Adverse event note: Per web report received by local County Public Health Department and per local Immunization Registry.   COVID Vaccination information: Moderna 2/4/2021 043L20A Moderna 3/4/2021 032M20A Pfizer 9/29/2021 30155BA Moderna 6/22/2022 014B22A Patient presented to Hospital ED with a chief complaint of 2 falls. This patient was recently admitted for an appendectomy on 10/28/2022. He states that he had been home for a little more than a day and he had 2 falls 1 of those out of bed and another 1 onto the ground. He had difficulty getting up both times. Patient denied complaints of shortness of breath, cough. Patient stated he had a normal appetite but stated that he is constipated. Denies chest pain, headaches, dizziness, lightheadedness, or dysuria. In the ER, the patient was found to be COVID-positive and requiring a supplemental oxygen. Per additional web report notes. ?This patient underwent an appendectomy on 10/28/2022, was discharged after an unremarkable hospital course, and presented to ED after having fallen twice at home within a 24-hour time span, found to be COVID-positive, and a presentation concerning for sepsis. The patient had noted that he had not had a bowel movement following surgery, however chart review demonstrates that the patient had been refused suppositories. The patient was empirically covered with zosyn and blood cultures where obtained which grew with g ram positive rods with subsequent repeat blood cultures without growth. The patient had a new oxygen requirement on admission prompting COVID treatment with dexamethason e and Remdesivir. His oxygen was subsequently weaned to one liter on the morning of 11/1/2022. That evening, a rapid response was called overhead after the patient had vomited and became profoundly hypoxic requiring an oxygen mask at 15 L. Shortly after transfer to the IC U, the patient had another emesis and aspiration event with subsequent respiratory/cardia c arrest with subsequent ROSC at first pulse check. The patient became hypotensive requiring vasopressors. Amiodarone was initiated due to new onset A-fib with RVR. Multiple blood gasses were drawn chest xrays obtained showing worsening respiratory failure and respiratory acidosis secondary to his aspiration. The patient suffered a second cardiac arrest with ROSC achieved after several rounds of CPR and epinephrine pushes. The patient's family made him a DNR following ROSC. The patient again became bradycardic at which point the family requested that we not treat and let him pass peacefully with his daughter present. The patient was pronounced dead at 01:08 on 11/02/2022. No further information
On 4/23/21, client received Moderna vaccine instead of second dose Pfizer.
Information has been received from a registered nurse referring to unspecified number of patients of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On unknown dates the patients were vaccinated with doses of improperly stored GARDASIL 9 or GARDASIL (dose, route, lot# and expiration date were not reported). Concomitant drug was reported. No adverse effects were reported. Additional information has been requested.
sore and swollen again; welts around the injection site; Initial soreness wore off; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (sore and swollen again), VACCINATION SITE BRUISING (welts around the injection site) and MYALGIA (Initial soreness wore off) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (sore and swollen again), VACCINATION SITE BRUISING (welts around the injection site) and MYALGIA (Initial soreness wore off). At the time of the report, SWELLING (sore and swollen again), VACCINATION SITE BRUISING (welts around the injection site) and MYALGIA (Initial soreness wore off) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter. Treatment information was not provided.
NO APPETITE; LOOSING WEIGHT; ABDOMINAL PAIN THAT FEELS LIKE STARVING; FEELING MISERABLE; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 2021 for prophylactic vaccination. The batch number was not reported, per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 2021, the subject experienced no appetite. On 2021, the subject experienced loosing weight. On 2021, the subject experienced abdominal pain that feels like starving. On 2021, the subject experienced feeling miserable. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the no appetite, loosing weight, abdominal pain that feels like starving and feeling miserable was not reported. This report was non-serious. This case, from the same reporter is linked to 20210511723.
Pt. here with (L) thigh swollen and red and hot since yesterday and day of vaccine 6/27. Received DTaP and MMR at the site (2 days ago). No fever, denies pain, normal gait, no hx reaction in the past to any vaccines. Plan: Diphenhydramine 12.5 mp/5 ml liquid-7 ml-po 3 times per day for 5 days prn allergic reaction. Ice. F/U ER if worsening.
Since I got the booster my peripheral neuropathy has gotten really bad Blood work and tests cannot find the reason.  I am concerned that booster;may be contributing because now i get burning and tingling throughout my body cannot sleep at not and this all began after booster.
This 4 year old male child received DTaP immunization 0.5 ml IM in his left anterior thigh. On 02Aug2010 the child also received IPV, varicella, and MMR as part of his 4 year old well child exam. On 04Aug2010 the child was taken to the hospital clinic for redness and swelling on his thigh at the immunization site which was identified as cellulitis. On 04Aug2010 because the child's sister had a cellulitis infection two days prior to the redness and swelling, the child was started on an unspecified dose of Keflex. As of 05Aug2010 the redness and swelling are better.
Received first vaccine at about 330 PM. on 1/19.  On Thursday, my left eye got really red and I had some blurring of vision.    I had a regularly scheduled eye doctor appointment the following Monday  1/25 and I waited until then to get checked out.  My eye pressure in my right eye was 18, a few ticks above what it has been running.  The eye pressure in my left eye was 45, extremely high.  My eye doctor prescribed some steroids'  and other eye pressure drops and he wanted to see me the next morning.  By then I had three does of these new drops.  The next morning my right eye pressure dropped to 16 and my left eye, the problem eye dropped to 10.  We kept eye drop regiment for two weeks and set another appointment following my second vaccine shot to see if there was a reaction.  It turns out that my left eye pressure was 11.  Now we don't knw if virus vaccine was responsible or not.  However the vaccine shots were the only new events in my life, so it became highly suspicious.
headache; Fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    This spontaneous case was reported by an other and describes the occurrence of HEADACHE (headache) and FATIGUE (Fatigue) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced HEADACHE (headache) and FATIGUE (Fatigue). At the time of the report, HEADACHE (headache) and FATIGUE (Fatigue) outcome was unknown.            no concomitant medication reported no treatment information provided. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable   Reporter did not allow further contact
4 YR OLD MALE WITH HISTORY OF COMPLEX PARTIAL EPILEPSY. CHIARI 1 MALFORMATION WHO PRESENTED TO HOSP IN WITH GTC LASTING 20 MINUTES WITH POST ICTAL STATE OF 10 MINUTES. PT RECEIVED 2 DOSES RECTAL OF DIASTAT TO STOP ACTIVITY. KEPPRA INCREASED FROM 2 ML TO 2.5 MLS TWICE A DAY FOR ONE WEEK AND THEN INCREASE TO 3 ML TWICE A DAY.
Patient (Female age 13) went to play tennis at 10 AM. Around 10:25 AM she felt very dizzy and had a temporary loss of sight. Her coach gave her some electrolytes and she was fine after that. We are not sure if this is a side effect of the vaccine or not. But she has never had such an episode before.  Google says it is due to lower blood pressure.
A report has been received from a Health Professional concerning a 5 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient received expired product which started on 06-May-2014. The outcome of the event of administration of expired product is unknown. The report was considered to be non-serious by reporter.
Moderna vaccine was given to a wrong aged patient. The first dose vaccine was not given at this clinic but was noted when the patient presented for a 2nd dose. Mother was unsure of the facility where the vaccination occurred. Vaccination card lists "nurse" as the healthcare professional/clinical site. Per mother there were no adverse reactions.
Pt recv vax on 3/9/99; on 3/10/99 pt exp itching of rt arm w/ vax site swelling
fussy, irritable, fever to 103, maculopapular rash (fine & mild); tx APAP & reassurance
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. Pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On an unknown date the patients were vaccinated with improperly  stored doses of VARIVAX (Merck) or PROQUAD (Merck), lot # K016425, expiration date 26-MAR-2016; lot # L009209, expiration date 17-SEP-2016; or, lot # L004005, expiration date 05-AUG-2016 (dose, dose number, route and anatomical location were unspecified). No adverse effects reported. Concomitant therapies were not reported. Lot numbers reported are valid only for PROQUAD (Merck). Additional information has been requested.